Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The human tri-peptide GHK and tissue remodeling 4
Tirzepatide (Mounjaro/Zepbound) has demonstrated greater weight loss than semaglutide in clinical trials, with participants losing up to 22.5% of body weight
There is a theoretical case for using both in certain patients, targeting different physiological mechanisms simultaneously, though this approach is under evaluation and not yet standard of care
Patients need regular blood tests and check-ups
Account tools keep product browsing, orders, and rewards conveniently organized
US$ 29.96
US$ 29.09
US$ 29.95
US$ 28.13
US$ 24.02
US$ 23.26
